These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
468 related articles for article (PubMed ID: 26222618)
21. Characterization and prediction of natriuretic peptide "nonresponse" during heart failure management: results from the ProBNP Outpatient Tailored Chronic Heart Failure (PROTECT) and the NT-proBNP-Assisted Treatment to Lessen Serial Cardiac Readmissions and Death (BATTLESCARRED) study. Gaggin HK; Truong QA; Rehman SU; Mohammed AA; Bhardwaj A; Parks KA; Sullivan DA; Chen-Tournoux A; Moore SA; Richards AM; Troughton RW; Lainchbury JG; Weiner RB; Baggish AL; Semigran MJ; Januzzi JL Congest Heart Fail; 2013; 19(3):135-42. PubMed ID: 23279139 [TBL] [Abstract][Full Text] [Related]
22. [Predictive value of admission amino-terminal pro-B-type natriuretic peptide on in-hospital mortality in patients with decompensated heart failure]. Wei BQ; Yang YJ; Zhang J; Dou KF; Zhang YH; Huang XH; Kang LM; Zhang CL; Gu Q; Gao X; Yang YM; Dai Y; Yu LT; Zhang HM; Lü R Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Jun; 37(6):481-5. PubMed ID: 19927625 [TBL] [Abstract][Full Text] [Related]
23. [Heart fatty acid binding protein in patients hospitalized because of worsening heart failure. Relation to prognosis of death]. Mazovets OL; Trifonov IR; Katrukha AG; Bereznikova AV; Medvedeva MV; Deev AD; Gratsianksiĭ NA Kardiologiia; 2008; 48(1):24-9. PubMed ID: 18260992 [TBL] [Abstract][Full Text] [Related]
24. Heart failure mortality according to acute variations in N-terminal pro B-type natriuretic peptide and cystatin C levels. Carrasco-Sánchez FJ; Pérez-Calvo JI; Morales-Rull JL; Galisteo-Almeda L; Páez-Rubio I; Barón-Franco B; Aguayo-Canela M; Pujol-De la llave E J Cardiovasc Med (Hagerstown); 2014 Feb; 15(2):115-21. PubMed ID: 24522084 [TBL] [Abstract][Full Text] [Related]
26. The Association Between Cardiac Biomarker NT-proBNP and 30-Day Readmission or Mortality After Pediatric Congenital Heart Surgery. Parker DM; Everett AD; Stabler ME; Leyenaar J; Vricella L; Jacobs JP; Thiessen-Philbrook H; Parikh C; Greenberg JH; Brown JR World J Pediatr Congenit Heart Surg; 2019 Jul; 10(4):446-453. PubMed ID: 31307305 [TBL] [Abstract][Full Text] [Related]
27. [Prognostic value of N-terminal-pro-brain natriuretic peptide on admission in patients with chronic heart failure]. Wang F; Li W; Huang J; Wang L; Bian WY; Pang HM; Wang Y; Xu ZM; Li YS Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jan; 34(1):28-32. PubMed ID: 16626545 [TBL] [Abstract][Full Text] [Related]
29. Direct comparison of serial B-type natriuretic peptide and NT-proBNP levels for prediction of short- and long-term outcome in acute decompensated heart failure. Noveanu M; Breidthardt T; Potocki M; Reichlin T; Twerenbold R; Uthoff H; Socrates T; Arenja N; Reiter M; Meissner J; Heinisch C; Stalder S; Mueller C Crit Care; 2011; 15(1):R1. PubMed ID: 21208408 [TBL] [Abstract][Full Text] [Related]
30. NT-ProBNP reduction percentage during hospital stay predicts long-term mortality and readmission in heart failure patients. Verdiani V; Ognibene A; Rutili MS; Lombardo C; Bacci F; Terreni A; Nozzoli C J Cardiovasc Med (Hagerstown); 2008 Jul; 9(7):694-9. PubMed ID: 18545069 [TBL] [Abstract][Full Text] [Related]
31. N-terminal pro-B-type natriuretic peptide-guided therapy in patients hospitalized for acute heart failure. Carubelli V; Lombardi C; Lazzarini V; Bonadei I; Castrini AI; Gorga E; Richards AM; Metra M J Cardiovasc Med (Hagerstown); 2016 Nov; 17(11):828-39. PubMed ID: 27322401 [TBL] [Abstract][Full Text] [Related]
32. Importance of early combined N-terminal pro-brain natriuretic peptide and cardiac troponin T measurements for long-term risk stratification of patients with decompensated heart failure. Perna ER; Macin SM; Cimbaro Canella JP; Szyszko A; Franciosi V; Vargas Morales W; Bayol AP; Kriskovich JO; Medina F; Gonzalez Arjol B; Brizuela M J Heart Lung Transplant; 2006 Oct; 25(10):1230-40. PubMed ID: 17045936 [TBL] [Abstract][Full Text] [Related]
33. Prognosis of decompensated heart failure patients with preserved systolic function is predicted by NT-proBNP variations during hospitalization. Bettencourt P; Azevedo A; Fonseca L; Araújo JP; Ferreira S; Almeida R; Rocha-Goncalves F; Ferreira A Int J Cardiol; 2007 Apr; 117(1):75-9. PubMed ID: 16843555 [TBL] [Abstract][Full Text] [Related]
34. Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure. Aimo A; Januzzi JL; Mueller C; Mirò O; Pascual Figal DA; Jacob J; Herrero-Puente P; Llorens P; Wussler D; Kozhuharov N; Sabti Z; Breidthardt T; Vergaro G; Ripoli A; Prontera C; Saccaro L; Passino C; Emdin M Int J Cardiol; 2019 Oct; 293():137-142. PubMed ID: 31200964 [TBL] [Abstract][Full Text] [Related]
36. Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction. Salah K; Stienen S; Pinto YM; Eurlings LW; Metra M; Bayes-Genis A; Verdiani V; Tijssen JGP; Kok WE Heart; 2019 Aug; 105(15):1182-1189. PubMed ID: 30962192 [TBL] [Abstract][Full Text] [Related]
37. [Value of admission NT-proBNP in predicting in-hospital mortality in decompensated systolic heart failure]. Wei BQ; Yang YJ; Zhang J; Zhang YH; Kang LM; Dou KF; Wang D; Lü R; Gao X; Yu LT; Wang GG; Yang YM; Tan HQ; Zhu J Zhonghua Yi Xue Za Zhi; 2009 Jul; 89(28):1955-9. PubMed ID: 19950568 [TBL] [Abstract][Full Text] [Related]
38. Pro-A-type natriuretic peptide, proadrenomedullin, and N-terminal pro-B-type natriuretic peptide used in a multimarker strategy in primary health care in risk assessment of patients with symptoms of heart failure. Alehagen U; Dahlström U; Rehfeld JF; Goetze JP J Card Fail; 2013 Jan; 19(1):31-9. PubMed ID: 23273592 [TBL] [Abstract][Full Text] [Related]